Host defenses and susceptibility to infection in patients with diabetes mellitus.

摘要: The recently completed Diabetes Control and Complications Trial (DCCT) provided compelling evidence that intensive treatment of people with insulin-dependent diabetes mellitus can delay or prevent diabetic microvascular complications. Although not studied in the DCCT, patients noninsulin-dependent likely will benefit from near-normoglycemia. it is difficult to prove a similar causal relation between hyperglycemia infection (this outcome was looked for DCCT), there substantial vitro data evolving clinical studies support this hypothesis. This information presented article following review regulation glucose levels.